Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Sep 2002
Randomized Controlled Trial Clinical TrialValsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study.
The objective of the study was to evaluate the effect of an angiotensin receptor blocker on left ventricular (LV) structure and function when added to prescribed heart failure therapy. ⋯ The Val-HeFT echocardiographic substudy of 5,010 patients with moderate heart failure demonstrated that valsartan therapy taken with either ACEI or BB reversed LV remodeling.